neutral avatar

Michele Iudici, MD, PhD

I graduated in rheumatology in 2011 and obtained my PhD in Clinical Immunology in 2015 at Seconda Università degli Studi di Napoli, Naples, Italie. Currently, I am a postdoctoral research fellow at Methods Team (INSERM- Sorbonne Paris Cité Epidemiology and Statistics Research Centre) and at Centre de Référence Maladies Systémiques Auto-Immunes Rares Vascularites Nécrosantes, Département de Médecine Interne, Hôpital Cochin, Université Paris – Descartes, Paris.

I conduct clinical research on connective tissue diseases and systemic vasculitides.

Orcid number : 0000-0001-5871-8806

Research interests

  • Connective tissue diseases

  • Systemic vasculitides

  • Risk of bias in survival analysis

Best publications

  • Iudici M, Pantano I, Fasano S, Pierro L, Charlier B, Pingeon M, Dal Piaz F, Filippelli A, Izzo V. Health status and concomitant prescription of immunosuppresants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. Lupus 2017 Jan 1 [Epub ahead of print].

  • Iudici M, Quartier P, Terrier B, Mouthon L, Guillevin L, Puéchal X. Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis. A systematic literature review and meta-analysis. Orphanet Journal of Rare Diseases, 2016;11:141.


  • Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick A, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S and Allanore Y. The European Scleroderma Trials and Research group (EUSTAR) Task Force for the Development of Revised Activity Criteria For Systemic Sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis, 2017;76:270-276.

  • Iudici M, Puéchal X, Pagnoux C, Quartier P, Agard C, Aouba A, Büchler M, Cevallos R, Cohen P, de Moreuil C, Guilpain P, Le Quellec A, Roblot P, Serratrice J, Bachmeyer C, Daugas E, Terrier B, Mouthon L, Guillevin L for the French Vasculitis Study Group. Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data from the French Vasculitis Study Group Registry. Arthritis & Rheumatol 2015;67:1959-65.

  • Iudici M, Cuomo G, Vettori S, Bocchino M, Sanduzzi Zamparelli A, Cappabianca S, Valentini G. Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders. Semin Arthritis Rheum. 2015;44:437-44.



  • Award Louis-Daniel Beauperthuy, Académie des sciences (2014)